The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Bayer
AstraZeneca
AccSalus Biosciences, Inc.
Merck Sharp & Dohme LLC
TransThera Sciences (Nanjing), Inc.
Elevation Oncology
DxTerity Diagnostics
TransThera Sciences (Nanjing), Inc.
MacroGenics
INSYS Therapeutics Inc
Auron Healthcare GmbH